Metabolism addiction in pancreatic cancer

R. Blum, Y. Kloog

Research output: Contribution to journalArticlepeer-review


Pancreatic ductal adenocarcinoma, an aggressively invasive, treatment-resistant malignancy and the fourth leading cause of cancer deaths in the United States, is usually detectable only when already inevitably fatal. Despite advances in genetic screening, mapping and molecular characterization, its pathology remains largely elusive. Renewed research interest in longstanding doctrines of tumor metabolism has led to the emergence of aberrant signaling pathways as critical factors modulating central metabolic networks that fuel pancreatic tumors. Such pathways, including those of Ras signaling, glutamine-regulatory enzymes, lipid metabolism and autophagy, are directly affected by genetic mutations and extreme tumor microenvironments that typify pancreatic tumor cells. Elucidation of these metabolic networks can be expected to yield more potent therapies against this deadly disease.

Original languageEnglish
Article numbere1065
JournalCell Death and Disease
Issue number2
StatePublished - Feb 2014


  • glutamine metabolism
  • glycolysis
  • metabolism
  • oncogenic Ras
  • pancreatic cancer
  • pentose phosphate pathway


Dive into the research topics of 'Metabolism addiction in pancreatic cancer'. Together they form a unique fingerprint.

Cite this